Cancer
Malignant Lip and Oral Cavity Neoplasm
CI-CAN-00001138Explore in graph →
Top-level149 active trials2 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001138Explore in graph →
Clinical trials
554 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (53)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05872880 | TPExtreme Induced Chemotherapy Followed by Surgery and Radiotherapy in the Oral Carcinoma. | recruiting | — | 124 | Xiangya Hospital of Central South UniversityOTHER | 1 | May 24, 2023 | clinicaltrials |
| NCT05375266 | Immune Biomarker Study for Head and Neck Cancer(ImmunBio-KHT) | recruiting | — | 1,100 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | May 17, 2023 |
| clinicaltrials |
| NCT03555721 | CytID Analysis of Oral Lesions | terminated | — | 18 | The University of Texas Health Science Center, HoustonOTHER | 1 | May 10, 2023 | clinicaltrials |
| NCT05843032 | 3D Ultrasound, Specimen Examination by Surgeon, and MRI in Surgical Margin Assessment | unknown | N/A | 27 | Rigshospitalet, DenmarkOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT05698667 | Outpatient Ultrasound for the Diagnostic Work-up of Oropharynx Cancer | completed | N/A | 26 | Rigshospitalet, DenmarkOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT01531881 | Autofluorescence Detection of Oral Malignancies and Database and Biospecimen Collection to Identify Biomarkers of Head and Neck Tumor Progression | completed | — | 240 | Roswell Park Cancer InstituteOTHER | 1 | Apr 28, 2023 | clinicaltrials |
| NCT05833841 | Swallowing Function in Patients With Head and Neck Cancers | completed | N/A | 50 | Banaras Hindu UniversityOTHER | 1 | Apr 27, 2023 | clinicaltrials |
| NCT05821179 | Salivary LINC00657 as a Diagnostic Biomarker for Oral Squamous Cell Carcinoma | completed | — | 36 | Fayoum UniversityOTHER | 1 | Apr 20, 2023 | clinicaltrials |
| NCT05806073 | Elective vs Therapeutic Neck Dissection in Treatment of Patients With Clinical T1/2N1M0 Oral Squamous Cell Carcinoma | not yet recruiting | N/A | 188 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 0 | Apr 12, 2023 | clinicaltrials |
| NCT05803915 | Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy | unknown | Phase 2 | 57 | Peking Union Medical College HospitalOTHER | 1 | Apr 7, 2023 | clinicaltrials |
| NCT04413214 | Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic HNSCC (Non NPC): A Phase I Trial | completed | Phase 1 | 9 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Apr 5, 2023 | clinicaltrials |
| NCT01332279 | Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy | withdrawn | Phase 1 | 0 | Fox Chase Cancer CenterOTHER | 1 | Apr 4, 2023 | clinicaltrials |
| NCT03385720 | Submandibular Gland Preservation in Neck Dissection | recruiting | N/A | 200 | Guang-Yan YuOTHER | 1 | Mar 30, 2023 | clinicaltrials |
| NCT04614896 | Use of Ultrasound for Measuring Size of Oral Tongue Cancers | completed | N/A | 30 | Rigshospitalet, DenmarkOTHER | 1 | Mar 30, 2023 | clinicaltrials |
| NCT02582008 | Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy | terminated | Early Phase 1 | 9 | Wake Forest University Health SciencesOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT05766150 | Oral Microbioma and Oral Malignant Disease | unknown | — | 300 | Academisch Ziekenhuis MaastrichtOTHER | 1 | Mar 13, 2023 | clinicaltrials |
| NCT05740774 | Surgical Margin Assessment by 3D Ultrasound | unknown | N/A | 7 | Rigshospitalet, DenmarkOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT01958762 | Screening for Cancers in the Oral CAvity(IDECAB) | recruiting | N/A | 100 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05578170 | Efficacy and Safety of Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous Cell Carcinoma(PROBES) | unknown | — | 47 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Feb 3, 2023 | clinicaltrials |
| NCT04430842 | Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S | completed | Phase 1 | 15 | Quadriga Biosciences, Inc.INDUSTRY | 1 | Jan 18, 2023 | clinicaltrials |
| NCT03032250 | Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer | completed | N/A | 35 | Wake Forest University Health SciencesOTHER | 1 | Jan 9, 2023 | clinicaltrials |
| NCT05512767 | A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation | withdrawn | N/A | 0 | Mayo ClinicOTHER | 0 | Jan 6, 2023 | clinicaltrials |
| NCT05611463 | Camrelizumab Plus Docetaxel and Cisplatin in Recurrent or Metastatic Oral Squamous Cell Carcinoma Patients(CHANCE) | unknown | Phase 2 | 25 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | Nov 10, 2022 | clinicaltrials |
| NCT05003427 | 68Ga-FAPI-04 PET/CT for the Detection of Oral Carcinoma | unknown | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT03502148 | Safety and Efficacy Study of PRV111 in Subjects With Oral Squamous Cell Carcinoma(PRV111) | completed | Phase 1 / Phase 2 | 10 | Privo TechnologiesINDUSTRY | 1 | Oct 21, 2022 | clinicaltrials |
| NCT05562375 | Predictive Value of GOCCLES® Device for Early Diagnosis of Oral Potentially Malignant Disorders | recruiting | N/A | 73 | Universidad Rey Juan CarlosOTHER | 1 | Oct 4, 2022 | clinicaltrials |
| NCT02295540 | Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity | withdrawn | N/A | 0 | Rutgers, The State University of New JerseyOTHER | 1 | Sep 28, 2022 | clinicaltrials |
| NCT05024383 | Dissecting the Heterogeneity of Oral Cancer Pain | unknown | N/A | 80 | NYU College of DentistryOTHER | 1 | Sep 28, 2022 | clinicaltrials |
| NCT01265849 | Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity(IT-MATTERS) | completed | Phase 3 | 928 | CEL-SCI CorporationINDUSTRY | 23 | Aug 19, 2022 | clinicaltrials |
| NCT03148665 | Saliva-based Detection of CD44(Detect 44) | completed | — | 85 | Joseph CalifanoOTHER | 1 | Aug 17, 2022 | clinicaltrials |
| NCT04831450 | Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC) | withdrawn | Phase 2 | 0 | University of MiamiOTHER | 0 | Aug 4, 2022 | clinicaltrials |
| NCT00470496 | Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer | completed | Phase 1 | 15 | Roswell Park Cancer InstituteOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT05456022 | Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line | unknown | Phase 2 | 1,000,000 | Cairo UniversityOTHER | 1 | Jul 13, 2022 | clinicaltrials |
| NCT03090412 | Photodynamic Therapy With HPPH Compared to Standard of Care Surgery in Treating Patients With Oral Cavity Cancer | terminated | Phase 2 | 2 | Roswell Park Cancer InstituteOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT01884259 | Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN(HNO-2) | completed | Phase 2 | 100 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | May 26, 2022 | clinicaltrials |
| NCT04955197 | Exfoliated Cytology in Detection of Oral Premalignant and Malignant Lesions | unknown | — | 48 | Cairo UniversityOTHER | 1 | May 25, 2022 | clinicaltrials |
| NCT02748707 | Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study(ERLO-XIB) | unknown | Phase 2 | 64 | Tata Memorial HospitalOTHER_GOV | 1 | Apr 28, 2022 | clinicaltrials |
| NCT01636544 | Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral Cavity(INECOC) | completed | N/A | 100 | Institut PasteurINDUSTRY | 1 | Apr 26, 2022 | clinicaltrials |
| NCT05296811 | Lateral Arm Free Flap for Reconstruction of the Oral Cavity and Head and Neck Soft Tissue Defects. | unknown | N/A | 15 | hassan harby mohamedOTHER | 1 | Mar 25, 2022 | clinicaltrials |
| NCT02873819 | Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity | completed | Phase 2 | 80 | Gliknik Inc.INDUSTRY | 7 | Mar 8, 2022 | clinicaltrials |
| NCT00964977 | Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis. | completed | Phase 3 | 209 | Johannes Gutenberg University MainzOTHER | 3 | Feb 25, 2022 | clinicaltrials |
| NCT05150509 | Association of Salivary Amino Acid Level With OSCC Identified By Liquid Chromatography Mass Spectroscopy(OSCC) | unknown | — | 110 | DR. MALA KHANOTHER_GOV | 1 | Feb 22, 2022 | clinicaltrials |
| NCT04059861 | Ultrasound in Tongue Cancer- a Help to Decide Depth of Invasion and to Improve the Surgical Margin | completed | N/A | 42 | Region Örebro CountyOTHER | 1 | Dec 27, 2021 | clinicaltrials |
| NCT04166214 | Oral Pathology Asynchronous Telementoring Pilot Study | completed | N/A | 51 | NYU Langone HealthOTHER | 1 | Dec 3, 2021 | clinicaltrials |
| NCT03267914 | Impact of Compliance With Fluoride Use on Caries Incidence After Cancer Therapy | completed | N/A | 20 | A.T. Still University of Health SciencesOTHER | 1 | Nov 24, 2021 | clinicaltrials |
| NCT03510390 | Metformin in Head and Neck Squamous Cell Carcinoma: Effect on Tissue Oxygenation(HEAD-MET) | completed | N/A | 17 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Nov 18, 2021 | clinicaltrials |
| NCT04367909 | A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma | unknown | Phase 2 | 68 | Xin-Hua XuOTHER | 1 | Nov 8, 2021 | clinicaltrials |
| NCT03096808 | Adaptive Radiotherapy for Head and Neck Cancer | completed | Phase 2 | 64 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 26, 2021 | clinicaltrials |
| NCT03843515 | Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction(NeoNivo) | unknown | Phase 1 | 17 | Amsterdam UMC, location VUmcOTHER | 1 | Oct 8, 2021 | clinicaltrials |
Data updated 23 days agoSource updated May 24, 2023source: clinicaltrials